Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-25-036321
Filing Date
2025-09-26
Accepted
2025-09-26 16:59:17
Documents
15
Effectiveness Date
2025-09-26

Document Format Files

Seq Description Document Type Size
1 S-8 ef20055971_s8.htm S-8 49881
2 EXHIBIT 5.1 ef20055971_ex5-1.htm EX-5.1 9665
3 EXHIBIT 23.1 ef20055971_ex23-1.htm EX-23.1 1683
4 ef20055971_ex107.htm   iXBRL EX-FILING FEES 19027
5 image0.jpg GRAPHIC 34391
  Complete submission text file 0001140361-25-036321.txt   253221

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20055971_ex107_htm.xml XML 7737
Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713 248-681-9815
Opus Genetics, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-290551 | Film No.: 251351235
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)